Source link : https://www.newshealth.biz/health-news/adding-targeted-agent-to-perioperative-therapy-for-rcc-may-improve-disease-control/
LOUISVILLE, Ky. — Tumor outcomes and thrombus control in renal cell carcinoma (RCC) improved with perioperative treatment that included a targeted agent plus immunotherapy, a small retrospective analysis showed. Immuno-oncology (IO) followed by a tyrosine kinase inhibitor (TKI) led to an objective response rate of 32.1% versus 22.2% in patients who received an IO regimen […]
Author : News Health
Publish date : 2024-11-11 20:32:29
Copyright for syndicated content belongs to the linked Source.
inHealth